ARTICLES

Arias, Cesar A.; Murray, Barbara E. (2009). “Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge“. New England Journal of Medicine 360 (5): 439-443.

S. Christian Cheatham, Pharm.D.; Michael B. Kays, Pharm.D.; David W. Smith,  Pharm.D.; Matthew F. Wack, M.D.; Kevin M. Sowinski, Pharm.D.(2008). “Steady-State Pharmacokinetics and Pharmacodynamics of Meropenem in Hospitalized Patients”. Pharmacotherapy 28 (6): 691-698.

Michael B. Kays, Pharm.D.; George G. Zhanel, Ph.D.; Megan A. Reimann, Pharm.D.; Judi Jacobi, Pharm.D.;Gerald A. Denys, Ph.D.; David W. Smith, Pharm.D.; Matthew F. Wack, M.D. (2007). “Selection of a gyrA Mutation and Treatment Failure with Gatifloxacin in a Patient with Streptococcus pneumoniae with a Preexisting parC Mutation”. Pharmacotherapy 27 (2): 221-226.

Michael B. Kays, Pharm.D.; David W. Smith, Pharm.D.; Matthew F. Wack, M.D.; Gerald A. Denys, Ph.D. (2002). “Levofloxacin Treatment Failure in a Patient With Fluoroquinolone-Resistant Streptococcus pneumoniae Pneumonia”. Pharmacotherapy 22 (3): 395-399.

EXTERNAL LINKS

Centers for Disease Control and Prevention

Antibiotic/Antimicrobial Resistance

Healthcare-associated Infections (HAI)